Dr. Megan Levings and her team have recently published two papers on the very different functions and uses of regulatory T cells (Tregs). Tregs are immune cells that help to rein in immune responses to ensure that they don’t go too far and begin harming healthy tissues in their pursuit of foreign invaders.
Lead
The Rare Disease Group envisions becoming a patient-centred leader in the field of rare disease discovery and innovation.
A multi-disciplinary team of clinicians and researchers, our members are focussed on discovering how genes lead to disease and developing innovative treatment strategies to improve outcomes for rare disease patients in BC and beyond.
